"Imar" Sp. z o.o. (Warsaw) (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing

Secondary Activities: All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers | Other Depository Credit Intermediation | Real Estate Property Managers | Administrative Management and General Management Consulting Services

Full name: "Imar" Sp. z o.o.

Profile Updated: May 31, 2025

"Imar" Sp. z o.o. (Warsaw) is a company in Poland, with a head office in Warsaw. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was established on October 28, 2002. The total number of employees is currently 1 (2025). Over the same period, its total assets grew by 3.46%.

Headquarters
Ul. Stanislawa Lencewicza 2A
Warsaw; Mazowieckie; Postal Code: 01-493

Contact Details: Purchase the "Imar" Sp. z o.o. (Warsaw) report to view the information.

Basic Information

Total Employees:

Purchase the "Imar" Sp. z o.o. (Warsaw) report to view the information.

Registered Capital:

Purchase the "Imar" Sp. z o.o. (Warsaw) report to view the information.

Financial Auditors:

Purchase the "Imar" Sp. z o.o. (Warsaw) report to view the information.

Incorporation Date:

October 28, 2002

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

90.99%

Subsidiaries

Imar Investments Sp. z o.o.

73.93%

Company Performance

Financial values in the chart are available after "Imar" Sp. z o.o. (Warsaw) report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating Profit

2.77%▲

Net Profit/Loss for the Period

2.77%▲

Total Assets

3.46%▲

Total Equity

-1.07%▼

Return on Equity (ROE)

0.02%▲

Similar companies